Genomic and transcriptomic plasticity in treatment-naive ovarian cancerIntravital characterization of tumor cell migration in pancreatic cancerDetailed imaging and genetic analysis reveal a secondary BRAF(L) (505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
author
nationality
type
label
Martijn P Lolkema